Vor Biopharma Inc.
VOR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001817229
In the last 90 days, Vor Biopharma Inc. insiders filed 0 open-market purchases and 1 sale; 102 institutions reported holding it in 13F filings for Q2 2026, worth $893.0M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Vor Biopharma Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 58 | 60 | +2 |
| Shares | 60.2M | 60.5M | +315.4K (+0.5%) |
| Value | $400.3M | $325.7M | −$74.6M (−18.6%) |
New holders (8)
Institutions that held Vor Biopharma Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of Montreal | 315,063 | $1.75M | 0.00% |
| Goldman Sachs Group Inc | 93,279 | $501.8K | 0.00% |
| Parkwood LLC | 21,744 | $117.0K | 0.02% |
| Virtu Financial LLC | 15,562 | $84.0K | 0.01% |
| Diametric Capital, LP | 12,902 | $69.4K | 0.03% |
| Balyasny Asset Management LLC | 12,627 | $67.9K | 0.00% |
| Jump Financial, LLC | 10,329 | $55.6K | 0.00% |
| Denali Advisors LLC | 6,500 | $35.0K | 0.01% |
Sold out (6)
Institutions that held Vor Biopharma Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| AWM Investment Company, Inc. | 100,000 | $665.0K |
| Tower Research Capital LLC (TRC) | 25,881 | $172.0K |
| Ergoteles LLC | 22,858 | $152.0K |
| Simplex Trading, LLC | 7,048 | $46.0K |
| UBS Group AG | 4,087 | $27.2K |
| Royal Bank of Canada | 838 | $6.00K |